Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed, 1 Injured in Crash at La Sierra Avenue and Lake Crest Drive


2 Vehicles Collide in Fatal Riverside Accident

Riverside, CA (April 8, 2020) – One person was killed in a crash in Riverside. The fatal accident occurred on the morning of April 8 at La Sierra Avenue and Lake Crest Drive.

Two vehicles collided at the intersection for unknown reasons. One person was killed in the crash. Another person suffered minor injuries.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Riverside 

#92503


February 4, 2020

Man Killed in Pedestrian Crash at Pacific Coast Highway and Caspian Avenue

Victim Hit by 2 Vehicles in Fatal Long Beach Accident...


January 2, 2020

1 Killed, 5 Injured in Crash on 10 Freeway Near Holt Avenue

4 Vehicles Involved in Fatal Chain-Reaction Accident in West Covina...


May 25, 2020

Jack McGarey Killed in Workplace Accident in California Department of Public Health Building

State Employee Electrocuted in Fatal Sacramento Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.